The per-patient costs of HIV services in South Africa: systematic review and application in the South African HIV investment case
G Meyer-Rath, C van Rensburg, C Chiu, R Leuner… - PloS one, 2019 - journals.plos.org
Background In economic analyses of HIV interventions, South Africa is often used as a case
in point, due to the availability of good epidemiological and programme data and the global …
in point, due to the availability of good epidemiological and programme data and the global …
The cost-effectiveness of antiretroviral treatment in Khayelitsha, South Africa–a primary data analysis
Background Given the size of the HIV epidemic in South Africa and other developing
countries, scaling up antiretroviral treatment (ART) represents one of the key public health …
countries, scaling up antiretroviral treatment (ART) represents one of the key public health …
Multi-country analysis of treatment costs for HIV/AIDS (MATCH): facility-level ART unit cost analysis in Ethiopia, Malawi, Rwanda, South Africa and Zambia
E Tagar, M Sundaram, K Condliffe, B Matatiyo… - PloS one, 2014 - journals.plos.org
Background Today's uncertain HIV funding landscape threatens to slow progress towards
treatment goals. Understanding the costs of antiretroviral therapy (ART) will be essential for …
treatment goals. Understanding the costs of antiretroviral therapy (ART) will be essential for …
The cost of treatment and care for people living with HIV infection: implications of published studies, 1999–2008
EJ Beck, G Harling, S Gerbase… - Current Opinion in HIV …, 2010 - journals.lww.com
Great variation was observed in the methods used to estimate cost data across the studies
identified, including range of services, patients covered and outcomes costed. Progress in …
identified, including range of services, patients covered and outcomes costed. Progress in …
The determinants of HIV treatment costs in resource limited settings
NA Menzies, AA Berruti, JM Blandford - PloS one, 2012 - journals.plos.org
Background Governments and international donors have partnered to provide free HIV
treatment to over 6 million individuals in low and middle-income countries. Understanding …
treatment to over 6 million individuals in low and middle-income countries. Understanding …
Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence
A Creese, K Floyd, A Alban, L Guinness - The Lancet, 2002 - thelancet.com
Background Evidence for cost-effectiveness of interventions for HIV/AIDS in Africa is
fragmentary. Cost-effectiveness is, however, highly relevant. African governments face …
fragmentary. Cost-effectiveness is, however, highly relevant. African governments face …
The economics of scaling up: cost estimation for HIV/AIDS interventions
L Kumaranayake - Aids, 2008 - journals.lww.com
Background: The scaling up of HIV/AIDS programming has been one of the most extensive
undertakings in international public health. Yet decision-makers are encountering significant …
undertakings in international public health. Yet decision-makers are encountering significant …
Revealed willingness-to-pay versus standard cost-effectiveness thresholds: Evidence from the South African HIV Investment Case
G Meyer-Rath, C Van Rensburg, B Larson… - PLoS …, 2017 - journals.plos.org
Background The use of cost-effectiveness thresholds based on a country's income per
capita has been criticized for not being relevant to decision making, in particular in middle …
capita has been criticized for not being relevant to decision making, in particular in middle …
[PDF][PDF] Is there scope for cost savings and efficiency gains in HIV services? A systematic review of the evidence from low-and middle-income countries
M Siapka, M Remme, CD Obure… - Bulletin of the World …, 2014 - SciELO Public Health
Objective To synthesize the data available–on costs, efficiency and economies of scale and
scope–for the six basic programmes of the UNAIDS Strategic Investment Framework, to …
scope–for the six basic programmes of the UNAIDS Strategic Investment Framework, to …
The future of financing for HIV services in Uganda and the wider sub-Saharan Africa region: should we ask patients to contribute to the cost of their care?
T Kakaire, W Schlech, A Coutinho, R Brough… - BMC public health, 2016 - Springer
Whilst multi-lateral funding for HIV/AIDS dramatically increased from 2004 to 2008, it has
largely plateaued in the last 8 years. Across sub-Saharan Africa, up to 20% of total spending …
largely plateaued in the last 8 years. Across sub-Saharan Africa, up to 20% of total spending …